“…5,81 In addition, studies have exhibited partial reduction of corneal neovascularization through topical, subconjunctival, and intraocular application of bevacizumab. 1,6,18,19,25,30,35,39,40,54–58,64,66,67,76,78,80,84,92,102,103,105,134,139,141 …”